<?xml version="1.0" encoding="UTF-8"?>
<p>The authors considered a 94% CI with an error margin set at 6%. Prevalence of 0.75 from previous studies by Fokam et al in same country was used for the sample size calculation. A sample size of 68 participants was obtained. Seventy treatment na√Øve patients were recruited, of these 63 samples amplified after RT-PCR and 61 sequences were retained for analysis after sequencing reaction. Analysis was done based on the 61 samples retained.</p>
